X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Dr. Reddys Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Quarterly Results   (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dr. Reddys Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m39,89039,67937,56232,22536,16337,23236,11933,332 
Other income Rs m320122307670438403205380 
Turnover Rs m40,21039,80137,86932,89536,60137,63536,32433,712 
Expenses Rs m30,95232,22332,79728,32329,89328,58730,21430,100 
Gross profit Rs m8,6187,5844,8243,9756,3558,7346,0073,330 
Depreciation Rs m0002,4362,6222,6652,5432,592 
Interest Rs m216622,646148126164196215 
Profit before tax Rs m8,7227,6442,4852,0614,0456,3083,473903 
Tax Rs m1,8791,7881,7395269561,38597237 
Profit after tax Rs m6,8435,8567461,5353,0894,9233,376666 
Gross profit margin %21.619.112.812.317.623.516.610.0 
Effective tax rate %21.523.470.025.523.622.02.826.2 
Net profit margin %17.214.82.04.88.513.29.32.0 
Diluted EPS Rs 41.3 35.3 4.5 9.3 18.6 29.7 20.4 4.0  
Diluted EPS (TTM) Rs 143.7 144.4 117.8 90.4 67.7 62.1 78.0 72.7  
 Subscriber Feature View     View       View  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   TTK HEALTHCARE  STRIDES SHASUN LTD  MERCK LTD  WYETH LTD  SANOFI INDIA  

Compare DR. REDDYS LAB With:   TTK HEALTHCARE  STRIDES SHASUN LTD  MERCK LTD  WYETH LTD  SANOFI INDIA  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Share Markets in India End Flat; Cipla & Bharti Airtel Top Gainers(Closing)

Share markets in India ended flat ahead of key corporate results and as profit booking in index heavyweights capped gains.

Views on news

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

25 Things PM Modi Did Not Tell You About the Indian Economy(Vivek Kaul's Diary)

Oct 9, 2017

There are way too many data points out there which clearly show that all is not well with the Indian economy.

The Multibaggers that will Rise from the Ashes of Disruption(Smart Contrarian)

Oct 4, 2017

Of new age asset-light businesses and an Indian player that ticks all the right boxes.

Invest in a 'Haunted House' Stock and Make a Killing(The 5 Minute Wrapup)

Oct 7, 2017

You can make a killing by buying non-commodity business in a commodity industry

Nifty 50 Constituents Change...Once Again(Daily Profit Hunter)

Oct 4, 2017

Does it make sense to look at long term charts when the index constituents are changing frequently?

BSE IPO Index vis-a-vis Sensex(Chart Of The Day)

Oct 7, 2017

IPO's have failed to beat the benchmark index in the past decade.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Oct 17, 2017 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - ACTAVIS COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS